Northwest Biotherapeutics reported $26.11M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agenus AGEN:US USD 13.46M 241K
AstraZeneca AZN:LN USD 29.3B 229M
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Cti Biopharma CTIC:US USD 109.84M 1.28M
Cytori Therapeutics CYTX:US USD 5.72M 311K
Cytrx CYTR:US USD 0 0
Eisai 4523:JP JPY 94.91B 8M
Merk MRK:US USD 30.42B 1.25B
Northwest Biotherapeutics NWBO:US USD 26.11M 339K
Roche Holding ROG:VX 27.75B 3.45B